Leslie Kean
Founding Scientist & Chief Scientific Officer Regatta Bio
Seminars
Wednesday 24th March 2027
Reviewing Clinical Development Strategies for Treg Therapies Across Global Studies
2:00 pm
- Examining the rationale for advancing complementary Treg clinical programs across multiple geographies and indications
- Evaluating early clinical observations from sorted Treg therapies in graft-versus-host disease and other immune-mediated settings
- Determining how emerging clinical data can guide future development priorities and broader application of Treg therapies